PPJ Healthcare Enterprises recently reached a strategic consulting agreement with Hemp Inc. to conduct medical marijuana potency tests through an affiliate lab that can test for THC, THCA, CBD, CBG, CBN, CBDA, beta-Caryophyllene, Linalool, beta-Myrcene and D-Limonene. The company believes that this agreement offers PPJ Healthcare Enterprises a unique opportunity to offer its extensive expertise in a burgeoning field.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.